Evidence that abnormalities of central neurohormonal systems are key to understanding fibromyalgia and chronic fatigue syndrome

Rheumatic Disease Clinics of North America

Volumn 22, Issue 2, 1996, Pages 267-284

  Crofford, L J ^a   Demitrack, M A ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROHORMONE; SEROTONIN;

ADRENERGIC SYSTEM; BEHAVIOR THERAPY; CHRONIC FATIGUE SYNDROME; COGNITIVE THERAPY; EMOTIONAL STRESS; FIBROMYALGIA; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; PRIORITY JOURNAL; REVIEW; STRESS;

EID: 0029877112     PISSN: 0889857X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-857X(05)70272-6     Document Type: Article

References (84)

1. Y.S. Allen R.E. Adrian J.M. Allen Neuropeptide Y distribution in the rat brain Science 221 1983 877 879
2. A.M.O. Bakheit P.O. Behan T.G. Dinan Possible upregulation of hypothalamic 5-hydroxytryptamine receptors in patients with postviral fatigue syndrome BMJ 304 1992 1010 1012
3. A.M.O. Bakheit P.O. Behan W.A. Watson Abnormal arginine-vasopressin secretion and water metabolism in patients with postviral fatigue syndrome Acta Neurol Scand 87 1993 234 238
4. G. Beard Neurasthenia, or nervous exhaustion Boston Medical and Surgical Journal III 1869 217 221
5. J. Beard T. Allain P. Coskeran Neuroendocrine responses to d-fenfluramine and insulin-induced hypoglycemia in chronic fatigue syndrome Biol Psychiatry 37 1995 245 252
6. R.M. Bennett S.R. Clark C.S. Burckhardt IGF-1 assays and other GH tests in 500 fibromyalgia patients Journal of Musculoskeletal Pain 3 suppl 1 1995 109
7. R.M. Bennett S.R. Clark S.M. Campbell Low levels of somatomedin C in patients with the fibromyalgia syndrome Arthritis Rheum 35 1992 1113 1116
8. M.R. Brown L.A. Fisher J. Spiess factor: Actions on the sympathetic nervous system and metabolism Endocrinology 111 1982 928 931
9. D. Buchwald D.L. Goldenberg J.L. Sullivan The 'chronic active Epstein-Barr virus infection' syndrome and primary fibromyalgia Arthritis Rheum 30 1987 1132 1136
10. C. Buckingham J.R. Hodges Hypothalamic receptors influencing the secretion of corticotrophin releasing hormone in the rat J Physiol 290 1979 421 431
11. P.W.J. Burnett I.N. Mefford C.C. Smith Hippocampal 8-[3H]hydroxy-2-(di-n-propylam ino) tetralin binding site densities, serotonin receptor (5HT1A) messenger ribonucleic acid abundance, and serotonin levels parallel the activity of the axis in rat J Neurochem 59 1992 1062 1070
12. B.J. Carroll M. Feingerg J.F. Greden A specific laboratory test for the diagnosis of melancholia: Standardization, validation, and clinical utility Archives of General Psychiatry 38 1981 15 22
13. G.P. Chrousos P.W. Gold The concepts of stress and stress system disorders: Overview of physical and behavioral homeostasis JAMA 267 1992 1244 1252
14. D.J. Clauw M. Sabol D. Radulovic Serum neuropeptides in patients with both fibromyalgia (FM) and chronic fatigue syndrome (CFS) Journal of Pain 3 suppl 1 1995 79
15. A.J. Cleare J. Bearn A. McGregor Contrasting neuroendocrine responses in depression and chronic fatigue syndrome Journal of Effective Disorders 35 1995 283 289
16. L.J. Crofford S.R. Pillemer K.T. Kalogeras Hypothalamic-pituitary-adrenal perturbations in patients with fibromyalgia Arthritis Rheum 37 1994 1583 1592
17. M.F. Dallman S.F. Akana N. Levin Corticosteroids and the control of function in the hypothalamo-pituitary-adrenal (HPA) axis Ann NY Acad Sci 746 1994 22 31
18. M.F. Dallman S.F. Akana K.A. Scribner Stress, feedback and facilitation in the axis J Neuroendocrinol 5 1992 517 526
19. M.A. Demitrack J.K. Dale S.E. Straus Evidence for impaired activation of the axis in patients with chronic syndrome J Clin Endocrinol Metab 73 1991 1224 1234
20. M.A. Demitrack P.W. Gold J.K. Dale Plasma and cerebrospinal fluid monoamine metabolism in patients with chronic fatigue syndrome: Preliminary findings Biol Psychiatry 32 1992 1065 1077
21. M.E. De Quidt P.C. Emson Distribution of neuropeptide Y-like immunoreactivity in the rat central nervous system-II. analysis Neuroscience 18 1986 545 618
22. M. Elam G. Johansson B.G. Wallin Do patients with primary fibromyalgia have an altered muscle sympathetic nerve activity? Pain 48 1992 371 375
23. G. Ferraccioli F. Cavalieri F. Salaffi Neuroendocrinologic findings in primary fibromyalgia (soft tissue chronic pain syndrome) and in other chronic rheumatic conditions (rheumatoid arthritis, low back pain) J Rheumatol 19 1990 869 873
24. D.L. Goldenberg Psychiatric and psychologic aspects of fibromyalgia syndrome Rheum Dis Clin North Am 15 1989 105 114
25. D.L. Goldenberg R.W. Simms A. Geiger High frequency of fibromyalgia in patients with chronic fatigue seen in a primary care practice Arthritis Rheum 33 1990 381 387
26. E.N. Griep J.W. Boersma E.P. de Kloet Altered reactivity of the axis in the primary syndrome J Rheumatol 20 1993 469 474
27. E.N. Griep J.W. Boersma E.R. de Kloet Pituitary release of growth hormone and prolactin in the primary fibromyalgia syndrome J Rheumatol 21 1994 2125 2130
28. D.A. Haas S.R. George Neuropeptide Y administration acutely increases hypothalamic corticotropin-releasing factor immunoreactivity: Lack of effect in other rat brain regions Life Sci 41 1987 2725 2731
29. M.S. Harbuz R.G. Rees D. Eckland Paradoxical responses of hypothalamic corticotropin-releasing factor (CRF) messenger ribonucleic acid (mRNA) and CRF-41 peptide and adenohypophysial proopiomelanacortin mRNA during chronic inflammatory stress Endocrinology 130 1992 1394 1400
30. I. Hickie A. Lloyd D. Wakefield The psychiatric status of patients with chronic fatigue Br J Psychiatry 156 1990 534 540
31. M.C. Holmes G. DiRenzy B. Gillham Role of serotonin in the control of secretion of corticotrophin releasing factor J Endocrinol 93 1982 151 160
32. J.I. Hudson D.L. Goldenberg H.G. Pope Comorbidity of fibromyalgia with medical and psychiatric disorders Am J Med 92 1992 363 367
33. J.B. Imboden A. Canter L.E. Cluff Convalescence from influenza Arch Intern Med 108 1961 393 399
34. J.B. Imboden A. Canter L.E. Cluff Psychological aspects of delayed convalescence Arch Intern Med 103 1959 78 86
35. M. Irwin M. Brown T. Patterson Neuropeptide Y and natural killer cell activity: Findings in depression and Alzheimer caregiver stress FASEB J 5 1991 3100 3107
36. M.T. Jones E.W. Hillhouse J. Burden Effect of various putative neurotransmitters on the secretion of hormone from the rat hypothalamus in vitro: A model of the involved J Endocrinol 69 1976 1 10
37. J.R. Joseph-Vanderpool N.E. Rosenthal G.P. Chrousos Abnormal pituitary-adrenal responses to CRH in patients with seasonal affective disorder: Clinical and pathophysiological implications J Clin Endocrinol Metab 72 1991 1382 1387
38. R.C. Kamilaris C.R. DeBold S.N. Pavlou Effect of altered thyroid hormone levels on adrenal function J Clin Endocrinol Metab 65 1987 994 999
39. Kamilaris TC, Calogero AE, Johnson EO: Effect of neuropeptide Y on function in the rat. Presented at the 19th Annual Meeting of the Society for Neuroscience. Phoenix, 1989
40. M.A. Kling A. Roy A.R. Doran Cerebrospinal fluid immunoreactive CRH and ACTH secretion in Cushing's disease and major depression Potential clinical J Clin Endocrinol Metab 72 1991 260 271
41. J.I. Koenig Regulation of the hypothalamo-pituitary axis by neuropeptide Y Ann N Y Acad Sci 611 1990 317 328
42. D.T. Krieger F. Rizzo Serotonin mediation of circadian periodicity of plasma 17 Am J Physiol 217 1969 1703 1707
43. M.J.P. Kruesi J.K. Dale S.E. Straus Psychiatric diagnoses in patients with the chronic fatigue syndrome J Clin Psychiatry 50 1989 53 56
44. J.M. Lundberg A. Franco-Cereceda J.-S. Lacroix Neuropeptide Y and sympathetic Ann N Y Acad Sci 611 1990 166 174
45. P. Manu D.A. Matthews T.J. Lane Depression among patient with a chief complaint of chronic fatigue J Affect Disord 17 1989 165 172
46. G.A. McCain K.S. Tilbe Diurnal hormone variation in fibromyalgia syndrome: A comparison with rheumatoid arthritis J Rheumatol 16 suppl 19 1989 154 157
47. M.J. Meaney S. Bhatnagar S. Larocque Individual differences in the stress response and the hypothalamic CRF system Ann N Y Acad Sci 697 1993 70 85
48. M.J. Meaney J. Diorio D. Francis Environmental regulation of the development of glucocorticoid receptor systems in the rat forebrain Ann N Y Acad Sci 746 1994 260 273
49. G. Neeck W. Riedel Thyroid function in patients with fibromyalgia syndrome J Rheumatol 19 1992 1120 1122
50. V.K. Patchev K.T. Kalogeras P. Zelazowski Increased plasma hypothalamic content, and in vitro release of arginine vasopressin in inflammatory diseaseprone, hypothalamic hormone-deficient Lewis rats Endocrinology 131 1992 1453 1457
51. V.K. Patchev G. Mastorakos L.S. Brady Increased arginine vasopressin secretion may participate in the enhanced susceptibility of Lewis rats to inflammatory disease Neuroendocrinology 58 1993 106 110
52. P.M. Plotsky M.J. Meaney Early, postnatal experience alters hypothalamic corticotropin-releasing factor (CRF) RNA, median eminence CRF content and stress-induced release in adult rats Molecular Brain Research 18 1993 195 200
53. Z.-G. Qiao H. Vaeroy L. Mørkrid Electrodermal and microcirculatory activity in patients with fibromyalgia during baseline, acoustic stimulation and cold pressor tests J Rheumatol 18 1991 1383 1389
54. F.M. Quitkin P.J. McGrath J.W. Stewart Phenelzine and imipramine in mood reactive depressives: Further delineation of the syndrome of atypical depression Arch Gen Psychiatry 46 1989 787 793
55. N.E. Rosenthal D.A. Sack J.C. Gillin Seasonal affective disorder: A description of the syndrome and preliminary findings with light therapy Arch Gen Psychiatry 41 1984 72 80
56. I.J. Russell Neurohormonal aspects of fibromyalgia syndrome Rheum Dis Clin North Am 15 1989 149 168
57. I.J. Russell Neurohormonal: Abnormal laboratory findings related to pain and fatigue in fibromyalgia Journal of Musculoskeletal Pain 3 1995 59 65
58. 3H-imipramine uptake receptor density and serum serotonin levels in patients with syndrome J Rheumatol 19 1992 104 109
59. E.J. Sachar L. Hellman H.P. Roffwarg Disrupted 24 hour patterns of cortisol secretion in psychotic depressives Arch Gen Psychiatry 18 1973 19 24
60. R.M. Sapolsky M.P. Armanini D.R. Packan feedback inhibition of hormone secretagogue release: Relationship to corticosteroid receptor occupancy in various limbic sites Neuroendocrinology 51 1990 328 336
61. N.J. Sarlis H.S. Chowdrey A. Stephanou Chronic activation of the axis and loss of circadian rhythm during arthritis in the rat Endocrinology 130 1992 1775 1779
62. U. Scapagnini G.P. Moberg G.R. Van Loon Relation of brain 5-hydroxytryptamine content to the diurnal variation of plasma corticosterone in the rat Neuroendocrinology 7 1971 90 96
63. N. Shanks S. Larocque M.J. Meaney Neonatal endotoxin exposure alters the of the hypothalamic-pituitary-adrenal Early illness and later responsivity to stress J Neurosci 15 1995 376 384
64. W.W. Spink What is chronic brucellosis? Ann Intern Med 35 1951 358 374
65. E.M. Sternberg Hypoimmune fatigue syndromes: Diseases of the stress response? J Rheumatol 20 1993 418 421
66. E.M. Sternberg J.R. Glowa M.A. Smith Corticotropin releasing hormone related behavioral and neuroendocrine responses to stress in Lewis and Fischer rats Brain Res 570 1992 54 60
67. E.M. Sternberg W.S. Young III R. Bernardini A central nervous system defect in biosynthesis of hormone is associated with susceptibility to streptococcal cell wall arthritis in Lewis rats Proc Natl Acad Sci U S A 86 1989 4771 4775
68. R.E. Sutton G.F. Koob M. LeMoal factor produces behavioral activation in rats Nature 297 1982 331 333
69. M.G. Swain V. Patchev J. Vergella Suppression of axis responsiveness to stress a rat model of acute cholestasis J Clin Invest 91 1993 1903 1908
70. N.R. Swerdlow M.A. Geyer W.W. Vale Corticotropin-releasing factor potentiates acoustic startle in rats: Blockade by chlordiazepoxide. (Berl) 88 1982 147 152
71. N. Tomori S. Suda F. Tozawa Immunoreactive corticotropin-releasing factor concentrations in cerebrospinal fluid from patients with disorders J Clin Endocrinol 56 1983 1305 1307
72. H. Vaerøy R. Helle Ø. Førre Cerebrospinal fluid levels of β-endorphin in patients with fibromyalgia (fibrositis syndrome) J Rheumatol 15 1988 1804 1806
73. H. Vaerøy Z.-G. Qiao L. Mørkrid Altered sympathetic nervous system response in patients with fibromyalgia (fibrositis syndrome) J Rheumatol 16 1989 1460 1465
74. W. Vale J. Vaughan M. Smith Effects of synthetic ovine corticotropin-releasing factor, glucocorticoids, catecholamines, peptides, and other substances on cultured corticotropic cells Endocrinology 113 1983 1121 1131
75. R.J. Valentino Corticotropin-releasing hormone activates neurons of the locus coeruleus Brain Res 270 1983 363 367
76. R.J. Valentino Wehby RG: Corticotropin releasing factor: Evidence for a neurotransmitter role in the locus ceruleus during hemodynamic stress Neuroendocrinology 48 1988 674 677
77. N.C. Vamvakopoulos G.P. Chrousos Evidence of direct extrogenic regulation of human corticotropin-releasing hormone gene expression J Clin Invest 92 1993 1896 1902
78. J. Wasman S.M. Zatzkis Fibromyalgia and menopause: Examination of the relationship Postgrad Med 80 1986 165 171
79. R. Yehuda J.S. Meyer A role for serotonin in the hypothalamic-pituitary-adrenal to insulin stress Neuroendocrinology 38 1984 25 32
80. Young EA: The role of gonadal steroids in hypothalamic-pituitary-adrenal regulation. Crit Rev Neurobiol, in press
81. E.A. Young J. Kotun R.F. Haskett Dissociation between pituitary and adrenal suppression to dexamethasone in depression Arch Gen Psychiatry 50 1993 395 403
82. M.B. Yunus J.W. Dailey J.C. Aldag Plasma and urinary catecholamines in primary fibromyalgia: A controlled study J Rheumatol 19 1992 95 97
83. M.B. Yunus C.W. Denko A.T. Masi Serum beta endorphin in primary fibromyalgia syndrome: A controlled study J Rheumatol 13 1986 183 186
84. M.B. Yunus A.T. Masi J.J. Calabro Primary (fibrositis): Clinical study of 50 patients with matched normal controls Semin Arthritis Rheum 11 1981 151 171